p53-dependent downregulation of metastasis-associated laminin receptor

Oncogene

Volumn 21, Issue 49, 2002, Pages 7478-7487

  Modugno, Michele ^a,b   Tagliabue, Elda ^a   Ardini, Elena ^a   Berno, Valeria ^a   Galmozzi, Enrico ^a   De Bortoli, Michele ^c   Castronovo, Vincent ^d   Ménard, Sylvie ^a  

^a Pharmacia ^*

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CANDIOLO CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

AP 2; Laminin receptor; p53; Promoter; Transcriptional regulation

Indexed keywords

CIS ACTING ELEMENT; CISPLATIN; LAMININ RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR AP 2;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENE LOCATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; INTRON; METASTASIS; MUTAGENESIS; MUTATIONAL ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PRECIPITIN TESTS; RECEPTORS, LAMININ; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037168191     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205957     Document Type: Article

References (37)

1. Agoff SN, Hou J, Linzer DIH and Wu B. (1993). Science, 259, 84- 87.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. (1987). Current Protocols in Molecular Biology. John Wiley & Sons (ed). New York: Green Publishing Associated and Wiley-Interscience, pp 2.1.1-2.1.2.
3. Baker SJ, Markowitz S, Fearon ER, Willson JKV and Vogelstein B. (1990). Science, 249, 912-915.
4. Bates NP and Hurst HC. (1997). Oncogene, 15, 473-481.
5. Borellini F and Glazer RI. (1993). J. Biol. Chem., 268, 7923-7928.
6. Butò S, Tagliabue E, Aiello P, Ardini E, Magnifico A, Montuori N, Sobel ME, Colnaghi MI and Ménard S. (1997). Int. J. Biol. Markers, 12, 1-5.
7. Butò S, Tagliabue E, Ardini E, Magnifico A, Ghirelli C, van den Brûle F, Castronovo V, Colnaghi MI, Sobel ME and Ménard S. (1998). J. Cell Biochem., 69, 244-251.
8. Castronovo V and Sobel ME. (1990). Biochem. Biophys. Res. Commun., 68, 1110-1117.
9. Clausse N, Van den Brule F, Delvenne P, Jacobs N, Franzen-Detrooz E, Jackers P and Castronovo V. (1998). Biochem. Biophys. Res. Commun., 251, 564-569.
10. Di Leo A, Bajetta E, Biganzoli L, Bohm S, Fabbiani M, Gebbia V, Lupi G, Mariani L, Ménard S, Oriana S, Ottone F, Pilotti S, Riboldi G, Sava C, Spatti G, Zunino F and di Re F. (1995). Eur. J. Cancer, 31A, 2248-2254.
11. Foley J, Wysolmerski JJ, Broadus AE and Philbrick WM. (1996). Cancer Res., 56, 4056-4062.
12. Ginsberg D, Mechta F, Yaniv M and Oren M. (1991). Proc. Natl. Acad. Sci. USA, 88, 9979-9983.
13. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC. (1994). Nucleic Acids Res., 22, 3551-3555.
14. Iotsova V and Stehelin D. (1996). Cell Growth Differ., 7, 629-634.
15. Jackers P, Minoletti F, Belotti D, Clausse N, Sozzi G, Sobel ME and Castronovo V. (1996). Oncogene, 13, 495-503.
16. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
17. Landowski TH, Dratz EA and Starkey JR. (1995). Biochemistry, 34, 11276-11287.
18. Levine AJ. (1997). Cell, 88, 323-331.
19. Loging WT and Reisman D. (1999). Oncogene, 18, 7608-7615.
20. Marchuk D, Drumm M, Saulino A and Collins FS. (1991). Nucleic Acids Res., 19, 1154.
21. Martignone S, Pellegrini R, Villa E, Tandon NN, Mastroianni A, Tagliabue E, Ménard S and Colnaghi MI. (1992). Clin. Exp. Met., 10, 379-386.
22. McPherson LA and Weigel RJ. (1999). Nucleic Acids Res., 27, 4040-4049.
23. Ménard S, Castronovo V, Tagliabue E and Sobel ME. (1997). J. Cell Biochem., 67, 155-165.
24. Ménard S, Tagliabue E and Colnaghi MI. (1998). Breast Cancer Res. Treat., 52, 137-145.
25. Nadji M, Nassiri M, Fresno M, Terzian E and Morales AR. (1999). Cancer, 85, 432-436.
26. Pal S, Datta K and Mukhopadhyay D. (2001). Cancer Res., 61, 6952-6957.
27. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC and Zunino F. (1996). Cancer Res., 56, 556-562.
28. Perissi V, Menini N, Cottone E, Capello D, Sacco M, Montaldo F and De Bortoli M. (2000). Oncogene, 19, 280-288.
29. Perrem K, Rayner J, Voss T, Sturzbecher H, Jackson P and Braithwaite A. (1995). Oncogene, 11, 1299-1307.
30. Raghunath P, Sidhu GS, Coon HC, Liu K, Srikantan V and Maheshwari RK. (1993). J. Biol. Regul. Homeost. Agents, 7, 22-30.
31. Rao CN, Castronovo V, Schmitt MC, Wewer UM, Clay-smith AP, Liotta LA and Sobel ME. (1989). Biochemistry, 28, 7476-7486.
32. Righetti SC, Della Torre G, Pilotti S, Ménard S, Ottone F, Colnaghi MI, Pierotti MA, Lavarino C, Cornarotti M, Oriana S, Böhm S, Bresciani GL, Spatti G and Zunino F. (1996). Cancer Res., 56, 689-693.
33. Santhanam U, Ray A and Sehgal PB. (1991). Proc. Natl. Acad. Sci. USA, 88, 7605-7609.
34. Subler MA, Martin DW and Deb S. (1992). J. Virol., 66, 4757-4762.
35. Wigler M, Pellicer A, Silverstein S and Axel R. (1978). Cell, 14, 725-731.
36. Yao KS, Godwin AK, Johnson SW, Oxols RF, O'Dwyer PJ and Hamilton TC. (1995). Cancer Res., 55, 4367-4374.
37. Zeng YX, Somasundaram K and El-Deiry WS. (1997). Nat. Genet., 15, 78-82.